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upon stimulation with BCP crystals. Micromass cultures of wild type
and ttw/ttw chondrocytes revealed that BCP crystals induce production
of highly sulphated and calciﬁed matrix. Furthermore, BCP crystals
reduced proliferation of chondrocytes as evaluated via an MTT assay.
Investigating the mechanism behind this shift of the chondrocytes
towards a hypertrophic phenotypewe found an increase in b- catenin in
wild type chondrocytes stimulated with BCP but not MSU crystals and
ttw/ttw chondrocytes. Incubation of chondrocytes with BCP crystals led
to an increase in the basal Ca2þ amount of chondrocytes.
Conclusions: The calciﬁcation of articular cartilage seems to be asso-
ciated with activation of canonical WNT signalling and subsequent
hypertrophic differentiation of chondrocytes. Our data support the
notion that OA is characterized by the re-initiation of developmental
programms associated with endochondral ossiﬁcation.
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CALCINEURIN/NFAT SIGNALING IN CHONDROCYTE
DIFFERENTIATION: NFAT IS A CRUCIAL NEGATIVE REGULATOR OF
EARLY CHONDROGENESIS
G. Kim y,z, M. Han z, E. Lee z, Y. Jung z, H. Park z, S. Han y,z. yDept. of
Internal Med., Daegu Fatima Hosp., Daegu, REPUBLIC OF KOREA; z Lab.
for Arthritis and Bone Biology, Fatima Res. Inst., Daegu, REPUBLIC OF
KOREA
Purpose: The chondrogenic differentiation of mesenchymal progenitor
cells is under domination of Sox9. However, the precise mechanism
controlling Sox9 transcriptional activity is still unclear. We investigated
the role of calcineurin/NFAT signaling during early chondrogenic
differentiation.
Methods: Micromass culture system derived from E11.5 mouse limb
bud mesenchymal progenitor cells was used. To investigate the role of
NFATs in chondrogenic differentiation, we treated inhibitors of calci-
neurin or calcineurin-NFAT interaction, FK-506 (100 ng/ml) and VIVIT (1
mM), respectively. Micromass cultures were stained with Alcian blue
and ALP to visualize early chondrogenic differentiation and chon-
drocyte maturation, repectively. Matrix mineralization was assessed
with Von Kossa stain. Expression of RNA and proteinwas analyzed with
real-time PCR and Western blot analysis.
Results: In micromass culture condition, NFAT1, NFAT3 and NFAT4
reached their peak during early chondrogenesis, and then it gradually
decreased. However, NFAT2 was nearly not detected during chon-
drogenesis. Both FK-506 and VIVIT signiﬁcantly increased an Alcian
blue incorporation of micromass culture and expression of chondro-
genic markers like Sox9, Col2a1, and aggrecan in RNA and protein
level. Among NFATs, nuclear translocalization of NFAT3, and NFAT4
were attenuated by both FK-506 and VIVIT, but that of NFAT1 is not
affected, which suggest that the NFAT-mediated suppression of
chondrogenesis is depend on NFAT3, and NFAT4. To investigate
whether the effects of FK-506 and VIVIT on chondrocyte maturation,
we studied ALP staining and Col10 and MMP13 RNA expression, which
was enhanced by calcineurin inhibitor, FK-506, but not by VIVIT. On
the other hand, a matrix mineralization was attenuated by FK-506. To
investigate the mechanism of FK-506-mediated chondrocyte matura-
tion, we investigated BMP signaling. Among BMP ligands, FK-506
increased BMP6 expression, but not BMP2, BMP4, and BMP7. In
addition, FK-506 increased Smad1/5 phosphorylation 60 min after
treatment. FK-506 also attenuated ANK, ENPP1, and MGP expression
which is known to have a major role in matrix mineralization, but
VIVIT was not at day 14.
Conclusions: NFATs suppress early chondrogenesis and FK-506
increases chondrocyte maturation and inhibits matrix mineralization in
a NFAT-independent manner.
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EFFECTIVE MODULATION OF GPR22 SIGNALLING IN CHONDROCYTES
L-A. Guns, R.J. Lories, F. Cailotto. KU Leuven, Leuven, Belgium
Purpose: Osteoarthritis (OA) is the most common type of chronic joint
disease and a challenge for society as its prevalence increases in the
ageing population. A genome-wide association study (GWAS) identi-
ﬁed an association between OA and a gene cluster on chromosome 7.Within this cluster, we have proposed a role for G protein coupled
receptor (GPR) 22. This orphan receptor is found in OA cartilage while it
was not present in healthy cartilage. Activated GPR22 signals through
the G inhibitory pathway resulting in inhibition of adenyl cyclase and
consequently decreases protein kinase A (PKA) activity. In silico pre-
dictions (GPCR internet database, www.gpcr.org/7tm/) show that
GPR22 belongs to the purinergic 2Y12-14 family (P2Y12-14). Here we
aim to investigate potential antagonists for GPR22 to understand its
function in the complex disease processes of OA, in particular in
chondrocytes.
Methods: We used the ATDC5 chondrogenic cell line as model system.
Stably overexpressing GPR22 cells (GPR22þ) were cultured in triplicate
as high density micromasses (200, 000 cells/10 ml). Cells were treated
daily with ITS in DMEM/F12 medium for 14 days to induce chondro-
genesis. Mineralization was triggered with beta-glycerol-phosphate in
a-MEM medium from day 14 till day 21. Different chemical compounds
were added: a non-selective P2 purinergic antagonist PPADS (100 mM),
a P2X-purinoceptor antagonist iso-PPADS (100 mM), a highly potent
P2Y12 receptor antagonist PSB0739 (10 mM) and a selective antagonist
of the P2Y6 nucleotide receptor MRS2578 (10, 3.3 and 1 mM). We per-
formed in silico analyses of receptor domain homology using the
Multalin software to select P2Y6 and P2Y12 antagonists. Gene expres-
sion of purinoceptors in wild type (WT) undifferentiated and differ-
entiated ATDC5 and chondrogenic markers, including Aggrecan (Agg),
Collagen type 2 (Col2a1) and type 10 (Col10a1) and Matrix metal-
loprotease 13 (MMP13), were analyzed. Sulfated proteoglycan, miner-
alization and collagen content were quantiﬁed by Alcian Blue, Alizarin
Red, and Picosirius Red staining.
Results: Overexpression of GPR22 in the ATDC5 chondrogenic model
stimulates chondrocyte hypertrophy and accelerates calciﬁcation.
PPADS 100 mM strongly decreases the mineralized content and
increases the proteoglycan content in GPR22þ cells. iso-PPADs 100 mM
slightly increases the proteoglycan content. Agg is upregulated for both
compounds and a trend for increased Col2a1 and a decrease in MMP13
was observed. MRS2578 10 mM is toxic for GPR22þ cells while 3.3 and 1
mM decrease mineralisation and increase the proteoglycan content.
Addition of PSB0739 10mM does not translate into a changed GPR22
phenotype.
Conclusions: We conclude that a P2Y6 selective antagonist alters the
GPR22 overexpression phenotype. Therefore we bring functional evi-
dence that GPR22 may be a purinoreceptor, closer to the P2Y6 sub-
group rather than P2Y12-14. These ﬁndings can help us to elucidate the
role of GPR22 in osteoarthritis, and eventually deﬁne antagonists of
GPR22.
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THE PROCATABOLIC CYTOKINE INTERLEUKIN-1 ALFA INDUCES A
DYSREGULATION OF O-LINKED N-ACETYLGLUCOSAMINE MODIFIED
PROTEINS IN HUMAN OSTEOARTHRITIC CHONDROCYTES
A. Larra~naga-Vera, J. Andres-Bergos, S. Perez-Baos,
G. Herrero-Beaumont, R. Largo. IIS-Fundacion Jimenez Diaz, Madrid,
Spain
Purpose: Nuclear and cytoplasmic protein glycosylation by the addition
of O-linked N-Acetylglucosamine (O-GlcNAc) to serine and threonine
residues is a widespread post-translational modiﬁcation that has been
described in degenerative and age-related diseases, such as Alzheimers
and diabetes. This modiﬁcation is catalyzed by the O-GlcNAc transferase
(OGT) which uses UDP-GlcNAc as a donor, and O-GlcNAc can be
removed by the O-GlcNAc-glucosaminidase (OGA). We have seen that
O-GlcNAc glycosylation levels in the articular cartilage of patients with
OAwere increased as well as the expression of the different isoforms of
OGT and OGAwas dysregulated. The goal of this study was to assess if a
procatabolic cytokine, IL-1a, can be responsible of the changes in O-
GlcNAc system found in OA human cartilage.
Methods: OA knee articular cartilage was obtained during replacement
surgery. Twelve OA patients were included in this study (6 woman/6
men; mean age 713 years), with a Mankin score for knee specimens
between 11 and 14. Human osteoarthritic chondrocytes (HOC) were
isolated by protease digestion for primary culture. At conﬂuence, cells
were stimulated with different concentrations of IL-1a for different
doses and periods of time after they were deprived of serum for 48 h.
Fig. 1. The schematic diagram of the effects of inhibitors on protease
activation and cartilage degradation. Legend: The broad MMP inhibitor.
GM6001, almost completely inhibited the activation of Pro-ADAMTS-4.
Pro-MMP and cartilage breakdown. Surprisingly, tissue inhibitor of met-
alloproteinase (TIMP) -3 didn’t affect the activities of aggrecanases. But, it
blocked the activation of Pro-MMP-9, but not Pro-MMP-13, and inhibited
the release of MMP-derived aggrecan fragment. However, it induced an
increased release of CTX-II, the reason of which is unclear. Furin-like
proprotein convertase inhibitor (PCi) dramatically lowered the level of
active ADAMTS-4 and aggrecanase-mediated degradation, but oppositely
induced a huge release of active ADAMTS-5 to compensate the loss of
ADAMTS-4. PCi also increased the conversion of latent MMP-13 to active
form and the release of AGNxII. Blockade of cysteine proteases by E64
increased the level of active ADAMTS-4 and the release of type II collagen
fragment. Inhibition of serine proteases by Aprotinin prevented TNF-a and
OSM stimulated cartilage destruction through blocking the activation of
Pro-ADAMTS-4 and Pro-MMP13. Inhibition of aspartic protease by pep-
statin A had increased the level of active form of ADAMTS-4 and MMP-13
and the damage to type II collagen.
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assessed by western-blot employing speciﬁc antibodies.
Results: The amount of O-GlcNAcylated proteins was increased in
HOC 24 h after stimulation with different doses of IL-1a (1, 10 and
100 ng/ml), showing the highest accumulation with 10 ng/ml. This
concentration was chosen for stimulation of HOC during different
periods of time (3, 6, and 24 h). The increase in O-GlcNAc proteins
amount showed a peak of induction at 6 h. This accumulation occurs
especially in proteins between 50 to 150 KDa therefore showing a
similar O-GlcNAcylated proteins pattern to that observed in OA
cartilage. We also observed an increased expression of the three OGT
isoforms, nucleo-cytoplasmic (ncOGT), mitochondrial (mOGT) and
small (sOGT) in HOC as early as 3 h, although the peak of induction
was at 6 h. Three isoforms were increased in a similar grade,
without prevalence of sOGT as found in OA cartilage. IL-1a also
increased the presence of both OGA isoforms, long (OGA-L) and
short (OGA-S) after 3 and 6 h of stimuli. A clear prevalence of long
isoform was found along IL-1a stimulation whereas OGA-S had the
highest prevalence in OA cartilage.
Conclusions: To our knowledge, this is ﬁrst evidence of procatabolic
cytokines involvement in O-GlcNAc modiﬁcations. IL-1a can induce
accumulation of O-GlcNAc proteins in human OA chondrocytes.
Although both regulatory enzymes of this modiﬁcation, OGT and OGA,
are also increased with IL-1a stimulation, characteristic distribution of
the different isoforms in OA cartilage was not reached. IL-1a is in part
responsible of a dysregulation in the O-GlcNAc proteins modiﬁcation
during OA although other processes must be involved.
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THE EFFECT OF PROTEASE INHIBITORS ON THE INDCUTION OF
OSTEOARTHRITIS-RELATED BIOMARKERS IN BOVINE FULL-DEPTH
CARTILAGE EXPLANTS
Y. He y, Q. Zheng z, M. Jiang z, S. Sun y, T.G. Christiansen x, M.A. Karsdal y,
A.C. Bay-Jensen y. yNordic BioSci., Herlev, Denmark; zNordic BioSci.
Beijing, Beijing, China; xOrthopedic Dept., Gentofte Univ. Hosp., Hellerup,
Denmark
Purpose: The speciﬁc protease degradation of aggrecan and type II
collagen in the cartilage matrix is a critical step in pathology of
osteoarthritis(OA). Several proteases are involved in the degradation
of the matrix proteins,amongst those are the important matrix
metalloproteinase (MMP)-9 , -13 and aggrecanase-1 and -2
(ADAMTS-4 and -5). The aim of the study was to gain better
understanding on the proteolytical proﬁle and sequence of events of
cartilage degradation by measuring the level of activated MMPs and
ADAMTS, as well as their speciﬁc degradation products of aggrecan
and type II collagen in the conditioned medium of a well described
cartilage explants model. Furthermore, the changes of proﬁle in
response to various types of broad spectrum protease inhibitors in
explants were monitored.
Methods: Bovine full-depth cartilage explants stimulated withTumor
Necrosis Factor alpha (TNF-a) and Oncostatin M (OSM) were cultured
for 21days with or without a number of inhibitors targeting different
types of proteases. Monoclonal antibodies were raised against the
active sites of ADAMTS-4, -5, MMP-9 and -13, and 4 ELISAs were
developed and technically validated. These, as well as AGNx1 (frag-
ments of ADAMTS degraded aggrecan), AGNxII (fragments of MMP
degraded aggrecan), and CTX-II (MMP-derived type II collagen frag-
ments) were quantiﬁed in the conditioned medium of the explants
cultures.
Results: In summary, we found that i) no proteolytical activity was
induced by medium alone; ii) the release of active ADAMTS-4 started at
day 14 and peaked at day 21, whereas no active ADAMTS-5 was
measured in the supernatant throughout stimulation of TNF-a and
OSM. Both active MMP-9 and -13 were released from day 17 and peaked
at day 21; iii) ADAMTS-mediated aggrecan degradation fragment
release peaked at day 10, returning to background level at day 19. In
contrast, the MMP fragments AGNxII and CTX-II peaked at the late stage
of stimulation; iv) The different effects of various inhibitors on the level
of aggrecanases, MMPs and cartilage breakdown have been observed
(illustrated in Fig.1).
Conclusions: The activation of proteases is a key point in cartilage
degradation, which is regulated in a complicated and integratedcascade process. The compensatory mechanisms could be triggered
following the blockade of one enzyme. This study suggests that this
model and measurement of biomarkers can be a useful tool to clarify
the mechanism of action of compounds and speed up the process of
selective protease inhibitor discovery.290
ALTERED ION CHANNEL FUNCTION IN AN IN VITRO MODEL OF
INFLAMMATORY ARTHRITIS
R. Lewis y,z, E.J. Paddison y, M. Wegg y, R. Barrett-Jolley y,z. yUniv. of
Liverpool, Liverpool, United Kingdom; zD-BOARD European Consortium
for Biomarker Discovery, Liverpool, United Kingdom
Purpose: Chondrocytes possess a complex complement of membrane
ion channels, transporters and receptors, which have been shown to
have a range of functions within these cells; including maintenance of
membrane potential and cell volume regulation. Various transcript
studies have identiﬁed changes in ion channel gene expression with
osteoarthritis (OA), including aquaporin channels and calcium-selective
TRP channels. In vitro studies have shown that pro-inﬂammatory
cytokines can induce signiﬁcant chondrocyte apoptosis, one of the
hallmarks of OA. The aim of this study was to examine the function of
aquaporins and calcium-selective ion channels in healthy and cytokine-
stimulated cells.
Methods: Healthy cartilage was obtained from the stiﬂe and elbow
joints of young, skeletally mature bull terrier type dogs, euthanized for
unrelated veterinary reasons (aged2-3years; weight 12-15kg). Chon-
drocytes were isolated overnight at 37C using a 0.1% collagenase II
solution. The cell suspension was ﬁltered and washed before being
seeded into culture ﬂasks and cultured until conﬂuence was reached
(37C, 21% O2). Once cultures were established cells were split into two
groups: healthy control (standard DMEM supplemented with 2% pen-
icillin-streptomycin, 1% fungizone and 10% foetal calf serum) or
stimulated cells (DMEM as above plus TNFa and IL-1b both at 10ng/ml).
Chondroyctes were cytokine-stimulated for up to one week. Cells were
